|
(Health-NewsWire.Net, September 23, 2021 )
Market Overview
Microneedle drug delivery is a device made by arranging hundreds of Microneedles in arrays on a tiny patch to deliver a sufficient amount of drug to give a required therapeutic response. This creates a direct transport pathway for a drug to travel into the viable epidermis avoiding contact with nerve fibers and blood vessels present in the dermal layers. The different types of materials are used in the manufacturing of microneedle depending upon their properties, such as ceramic, silicon, silica glass, carbohydrate, and polymers.
View full report: https://bit.ly/3AAmQV4
Market Dynamics
The microneedles drug delivery market growth is due to the availability of safer alternatives to conventional hypodermic injection. Furthermore, growing adoption in safety issues is also fueling the growth of microneedle drug delivery. As percenters for disease control and prevention, introducing a new microneedle patch could make it easier to vaccinate people in case of preventable diseases. Thus, vaccinations for various medical conditions such as measles boost the demand for the microneedle drug delivery market. Also, the Microneedle patch can be administered by minimally trained healthcare workers.
Increasing prevalence of diabetes is expected to drive the growth in the forecast period
The market is expected to surge in the coming years due to the increasing prevalence of diabetes globally. According to the International Diabetes Federation, around 463 million adults had been living with diabetes in 2019, and the number has been expected to rise to 700 million by 2045. Microneedles have proven to be an effective way to provide and deliver insulin based on glucose levels in a patient’s body. For instance, in March 2020, a research team, which a UCLA bioengineering professor led, had created a novel and coin sizes adhesive polymer patch using microneedles. This development is expected to have a positive impact on the market in the coming years.
Growing vaccinations for various medical conditions such as measles boost the demand for the microneedle drug delivery market
According to the Centers for Disease Control and Prevention, a new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases. Measles, a highly contagious virus, can affect the population in large numbers, for which precautions during vaccine preparation and vaccination should be taken care of. Around 20 million people are affected with measles every year, and unfortunately, global coverage with the measles vaccine has been stagnant for the last few years at around 85%, which is below the coverage percentage. Hence, microneedle patches are designed to administer by minimally trained workers and simplify the storage, distribution, and disposal process.
Microneedles have few concerns like drug degradation, poor absorption are likely to hinder the market growth.
Drug degradation, local irritation, poor absorption, and variability in absorption are expected to hinder the microneedle drug delivery market growth. Another challenge with dissolving microneedles is the incomplete penetration of these devices into the skin leading to drug wastage. Delivery of macromolecules with high hydrophilicity and molecular weight through microneedles is a challenge for delivery across the skin's surface.
Segment Analysis
By Product Type
• Solid Microneedle Technology
• Hollow Microneedle Technology
By Application
• Cardiovascular
• Neurologic Conditions
By End-user
• Hospitals
• Diagnostic laboratories
• Life sciences and research laboratories
• Others
Download free sample: https://bit.ly/3CAePA7
Geographical Analysis
North America region holds the largest market share of the global microneedles drug delivery market
North America dominates the global microneedle drug delivery market due to high per capita healthcare expenditure in patient awareness. Early-phase diagnosis and treatment of disease and easy regulations for transdermal drug delivery vaccines drive the medical biotechnology market, which is expected to drive the microneedle drug delivery in North America. For instance, In June 2021, TSRL and PharmaTher announced that they had teamed up to develop microneedles patches. The novel partnership and collaboration would be used to collect and pool resources and intelligence to develop intradermal delivery devices for their use in therapeutic areas of field and focus. Both the companies had been involved in the development of the microneedle delivery system. Pharmacother had licensed microneedle technology from the University of California in the year 2020, and TSRL had been working on microneedle prototype patches, with support from the reputed National Institute of Allergy and Infectious Diseases.
Competitive Landscape
The global microneedles drug delivery market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include 3M, Vetter Pharma International GmbH, nano bioscience LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation, Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies, Innoture Medical Technology Limited, Phillips Plastic Corporation, Corium International, Inc., Stemedica Cell Technologies, Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, Zosano Pharma has unveiled its Qtrypta zolmitriptan intracutaneous microneedle system, for migraine treatments, which is being reviewed for approval by the FDA.
Related Topic's
Needles Market, Aspiration and Biopsy Needles Market, Aminocentesis Needles Market, Syringes and Needles Market, Needle Free Blood Drawing devices Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
